Literature DB >> 8778703

Sinus node dysfunction in tuberous sclerosis.

C G Cowley1, L Y Tani, V E Judd, R E Shaddy.   

Abstract

Tuberous sclerosis is an autosomal dominant disease with potential for involvement of the skin, brain, lungs, kidneys, and heart. A case of prolonged sinus node pause and episodes of unresponsiveness in a 21-week-old infant with tuberous sclerosis is described. The infant subsequently underwent placement of an epicardial pacemaker. This case illustrates the importance of electrocardiographic studies in infants with tuberous sclerosis and seizure-like episodes.

Entities:  

Mesh:

Year:  1996        PMID: 8778703     DOI: 10.1007/BF02505813

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  5 in total

1.  Tuberous sclerosis presenting with a cardiac arrhythmia.

Authors:  J Oettlé; L Schamroth
Journal:  Heart Lung       Date:  1976 Nov-Dec       Impact factor: 2.210

2.  Tuberous sclerosis presenting as cardiac arrhythmia.

Authors:  T R Taylor
Journal:  Br Heart J       Date:  1968-01

3.  Rhabdomyoma of the heart. Two unusual clinical presentations.

Authors:  R Golding; G Reed
Journal:  N Engl J Med       Date:  1967-04-27       Impact factor: 91.245

4.  Cardiac rhabdomyoma: a clinicopathologic and electron microscopic study.

Authors:  J J Fenoglio; H A MCAllister; V J Ferrans
Journal:  Am J Cardiol       Date:  1976-08       Impact factor: 2.778

5.  Tuberous sclerosis and cardiac arrhythmia in three Zulu patients.

Authors:  J E Cosnett; B H Gibb
Journal:  Br Med J       Date:  1969-06-14
  5 in total
  1 in total

Review 1.  Cardiovascular manifestations of tuberous sclerosis complex and summary of the revised diagnostic criteria and surveillance and management recommendations from the International Tuberous Sclerosis Consensus Group.

Authors:  Robert B Hinton; Ashwin Prakash; Robb L Romp; Darcy A Krueger; Timothy K Knilans
Journal:  J Am Heart Assoc       Date:  2014-11-25       Impact factor: 5.501

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.